Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Dutch multicenter trial of radioiodine treatment versus no treatment for endogenous subclinical hyperthyroidism
NL-OMON21676Recruiting
- Start
- Jun 2003
- Modality
- Antibody-Radionuclide Conjugates → Antibody Conjugates → Antibody-Based Therapeutics, Beta-minus Emitters → Radiopharmaceuticals, Gamma Emitters → Radiopharmaceuticals
- Countries
- 1
01
Overview
Randomised, open-label trial of iodine-131 in subclinical hyperthyroidism (2 arms). Primary endpoints: Progression to overt hyperthyroidism, Quality of life and 5 more. Started Jun 2003; status: recruiting.
02
Drugs
iodine-131
03
Conditions
subclinical hyperthyroidism
Beyond the preview
Go deeper on NL-OMON21676.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NL-OMON21676.